Nephrology and Dialysis Unit, San Raffaele Hospital Instituto di Ricovero e Cura a Carattere Scientifico, 20132 Milan, Italy.
J Clin Endocrinol Metab. 2013 Sep;98(9):3839-47. doi: 10.1210/jc.2013-1834. Epub 2013 Jul 17.
CaSR gene is a candidate for calcium nephrolithiasis. Single-nucleotide polymorphisms (SNPs) encompassing its regulatory region were associated with calcium nephrolithiasis.
We tested SNPs in the CaSR gene regulatory region associated with calcium nephrolithiasis and their effects in kidney.
One hundred sixty-seven idiopathic calcium stone formers and 214 healthy controls were genotyped for four CaSR gene SNPs identified by bioinformatics analysis as modifying transcription factor binding sites. Strontium excretion after an oral load was tested in 55 stone formers. Transcriptional activity induced by variant alleles at CaSR gene promoters was compared by luciferase reporter gene assay in HEK-293 and HKC-8 cells. CaSR and claudin-14 mRNA levels were measured by real-time PCR in 107 normal kidney medulla samples and compared in patients with different CaSR genotype.
Only rs6776158 (A>G), located in the promoter 1, was associated with nephrolithiasis. Its minor G allele was more frequent in stone formers than controls (37.8% vs 26.4%, P = .001). A reduced strontium excretion was observed in GG homozygous stone formers. Luciferase fluorescent activity was lower in cells transfected with the promoter 1 including G allele at rs6776158 than cells transfected with the A allele. CaSR mRNA levels were lower in kidney medulla samples from homozygous carriers for the G allele at rs6776158 than carriers for the A allele. Claudin-14 mRNA levels were also lower in GG homozygous subjects.
Minor allele at rs6776158 may predispose to calcium stones by decreasing transcriptional activity of the CaSR gene promoter 1 and CaSR expression in kidney tubules.
钙敏感受体(CaSR)基因是钙性肾结石的候选基因。其调控区的单核苷酸多态性(SNPs)与钙性肾结石有关。
我们检测了 CaSR 基因调控区与钙性肾结石相关的 SNPs 及其在肾脏中的作用。
通过生物信息学分析,鉴定出 4 个可能改变转录因子结合位点的 CaSR 基因 SNPs,对 167 例特发性钙结石形成者和 214 例健康对照者进行基因分型。对 55 例结石形成者进行口服负荷后锶排泄试验。通过荧光素酶报告基因检测在 HEK-293 和 HKC-8 细胞中比较变异等位基因在 CaSR 基因启动子上诱导的转录活性。在 107 例正常肾脏髓质样本中用实时 PCR 检测 CaSR 和 Claudin-14mRNA 水平,并比较不同 CaSR 基因型患者的水平。
只有位于启动子 1 上的 rs6776158(A>G)与肾结石有关。其 G 等位基因在结石形成者中比对照组更为常见(37.8%比 26.4%,P=0.001)。GG 纯合子结石形成者锶排泄减少。与转染 rs6776158 包含 G 等位基因的启动子 1 的细胞相比,转染包含 A 等位基因的细胞的荧光素酶荧光活性较低。rs6776158 的 G 等位基因纯合携带者肾脏髓质样本中的 CaSRmRNA 水平低于 A 等位基因携带者。Claudin-14mRNA 水平在 GG 纯合子受试者中也较低。
rs6776158 的次要等位基因可能通过降低 CaSR 基因启动子 1 的转录活性和肾脏小管中 CaSR 的表达,使个体易患钙结石。